Science | ABNewswire

Alcohol Use Disorder Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Alcohol Use Disorder Pipeline Insight 2025” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It covers the Alcohol Use Disorder pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Duchenne Muscular Dystrophy Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Schizophrenia Clinical Trial Pipeline Accelerates as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Schizophrenia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in the Schizophrenia pipeline landscape. It covers the Schizophrenia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Schizophrenia Pipeline … Continue reading →

Peanut Allergy Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Peanut Allergy Pipeline Insight, 2025” report provides comprehensive insights about 12+ companies and 15+ pipeline drugs in Peanut Allergy pipeline landscape. It covers the Peanut Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Leading Travel Aggregator | PROVAB Launches XML feed with Flights Including LCCs, Hotels, Cars, Transfers and Activities

With PROVAB, travel agencies and DMCs are deploying top travel technology solutions to increase topline and profits. PROVAB is one of the leading travel wholesalers and it has recently launched an upgraded version of Travel APIs with flights which include … Continue reading →

California Libraries Now Offer Free Ecosense EcoBlu Radon Monitors Through CDPH Program

A new statewide initiative expands radon awareness and provides residents with free, easy-to-use digital testing devices. Ecosense announced its partnership with the California Department of Public Health (CDPH) Indoor Radon Program to provide digital radon detection technology to all residents … Continue reading →

Breast Cancer Clinical Trial Pipeline Gains Momentum: 250+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Breast Cancer Pipeline Insight 2025” report provides comprehensive insights about 250+ Breast Cancer companies and 300+ pipeline drugs in the Breast Cancer pipeline landscape. It covers the Breast Cancer pipeline drugs profiles, including clinical and nonclinical stage products. It … Continue reading →

Wiskott-Aldrich Syndrome Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Wiskott-Aldrich Syndrome Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in the Wiskott-Aldrich Syndrome pipeline landscape. It covers the Wiskott-Aldrich Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Dilated Cardiomyopathy Treatment Pipeline Shows Strong Momentum as 8+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Dilated Cardiomyopathy Pipeline Insight 2025” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Dilated Cardiomyopathy pipeline landscape. It covers the Dilated Cardiomyopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Facioscapulohumeral Muscular Dystrophy Clinical Trial Pipeline Shows Potential with Active Contributions from 10+ Key Companies | DelveInsight

DelveInsight’s “Facioscapulohumeral Muscular Dystrophy Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in the Facioscapulohumeral Muscular Dystrophy pipeline landscape. It covers the Facioscapulohumeral Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Sunday - December 14, 2025

Category Archives: Science